Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study-Reference-Cited by-同舟云学术

Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study

Published:2018-07-17 Issue:11 Volume:65 Page:e27363
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Morgenstern Daniel A.¹²^ORCID,Pötschger Ulrike³,Moreno Lucas⁴,Papadakis Vassilios⁵,Owens Cormac⁶,Ash Shifra⁷^ORCID,Pasqualini Claudia⁸,Luksch Roberto⁹^ORCID,Garaventa Alberto¹⁰,Canete Adela¹¹,Elliot Martin¹²,Wieczorek Aleksandra¹³,Laureys Geneviève¹⁴,Kogner Per¹⁵,Malis Josef¹⁶,Ruud Ellen¹⁷,Beck-Popovic Maja¹⁸,Schleiermacher Gudrun¹⁹,Valteau-Couanet Dominique⁸,Ladenstein Ruth²⁰

Affiliation:

1. Paediatric Haematology/Oncology; Hospital for Sick Children and University of Toronto; Toronto Canada

2. Paediatric Haematology/Oncology; Great Ormond Street Hospital and UCL Institute of Child Health; London UK

3. Studies and Statistics on Integrated Research and Projects; St Anna Kinderkrebsforschung; Vienna Austria

4. Paediatric Haematology/Oncology; Hospital Nino Jesús; Madrid Spain

5. Paediatric Haematology/Oncology; Agia Sofia Children's Hospital; Athens Greece

6. Paediatric Haematology/Oncology; Our Lady's Children's Hospital; Crumlin Dublin Ireland

7. Paediatric Haematology/Oncology; Schneider Children's Medical Center of Israel; Petah Tikva Israel

8. Department of Paediatric and Adolescent Oncology; Institut Gustav Roussy; Viellejuif France

9. Dipartimento di Ematologia e Onco-ematologia Pediatrica; Fondazione IRCCS Istituto Nazionale dei Tumori; Milan Italy

10. Paediatric Oncology; Istituto Giannia Gaslini; Genova Italy

11. Pediatric Oncology Unit; Hospital Universitario y Politecnico La Fe; Valencia Spain

12. Paediatric Oncology; Leeds Teaching Hospital NHS Trust; Leeds UK

13. Department of Pediatric Oncology and Hematology; Institute of Pediatrics; Jagiellonian University Medical College; Krakow Poland

14. Department of Pediatric Hematology/Oncology and Stem Cell Transplantation University Hospital Ghent; Ghent Belgium

15. Department of Women's and Children's Health, Karolinska Institutet; Astrid Lindgren Children's Hospital; Karolinska University Hospital; Stockholm Sweden

16. Department of Pediatric Hematology and Oncology; University Hospital Motol; Prague Czech Republic

17. Department of Paediatric Medicine; Rikshospitalet; Oslo University Hospital; Oslo Norway

18. Department of Pediatrics and Pediatric Surgery; Pediatric Haematology Oncology Unit; University Hospital Lausanne; Lausanne Switzerland

19. Department of Paediatrics; Institut Curie; Paris France

20. Paediatric Haematology/Oncology; St Anna Kinderspital and St Anna Kinderkrebforschung; Vienna Austria

Funder

European Commission 5th Framework Grant

St Anna Kinderkrebsforschung

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.27363/fullpdf

Reference34 articles.

1. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report;Cohn;J Clin Oncol,2009

2. Neuroblastoma;Maris;Lancet,2007

3. Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: a study from the international neuroblastoma risk group database;Morgenstern;J Clin Oncol,2014

4. Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: a study from the International Neuroblastoma Risk Group database;Morgenstern;Eur J Cancer,2016

5. Lung metastases in neuroblastoma at initial diagnosis: a report from the International Neuroblastoma Risk Group (INRG) project;Dubois;Pediatr Blood Cancer,2008

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of Chromosome Y in Neuroblastoma Is Associated With High‐Risk Disease, 11q‐Deletion, and Telomere Maintenance;Genes, Chromosomes and Cancer;2024-07

2. Migration, invasion, and metastasis are mediated by P-Rex1 in neuroblastoma;Frontiers in Oncology;2024-05-31

3. Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics;Frontiers in Immunology;2024-04-09

4. Clinical Features at Diagnosis Are Associated With the Need of Emergency Invasive Procedures and Intensive Care Unit Admission in Patients With High-risk Neuroblastoma – A Retrospective Cohort Study;2023-12-20

5. Imaging biomarkers and radiomics in pediatric oncology: a view from the PRIMAGE (PRedictive In silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers) project;Pediatric Radiology;2023-09-25